Feedback / Questions
CB-5339 - Cleave Therap
CID-103 - CASI
CNCT19 - CASI, Juventas Cell Therapy
https://www.prnewswire.com/news-releases/casi-pharmaceuticals-announces-third-quarter-2022-financial-results-301676268.html
Nov 14, 2022
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next